HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Elin Borgen Selected Research

Growth Differentiation Factor 15

1/2020Serum levels of inflammation-related markers and metabolites predict response to neoadjuvant chemotherapy with and without bevacizumab in breast cancers.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Elin Borgen Research Topics

Disease

28Neoplasms (Cancer)
12/2021 - 10/2004
26Breast Neoplasms (Breast Cancer)
12/2021 - 10/2004
2Adenocarcinoma
01/2021 - 09/2015
2Residual Neoplasm
01/2021 - 11/2020
2Pathologic Complete Response
01/2021 - 01/2021
2Carcinoma (Carcinomatosis)
11/2020 - 09/2015
2Inflammation (Inflammations)
01/2020 - 01/2020
2Circulating Neoplastic Cells
01/2018 - 01/2014
2Neoplasm Metastasis (Metastasis)
01/2017 - 12/2016
1Pancreatic Diseases (Pancreatic Disease)
11/2020
1Infections
11/2020
1Hypertension (High Blood Pressure)
11/2020
1Febrile Neutropenia
11/2020
1Hemorrhage
11/2020
1Thrombosis (Thrombus)
01/2020
1Noninfiltrating Intraductal Carcinoma (DCIS)
01/2019
1Genomic Instability
11/2018
1Lymphatic Metastasis
12/2016
1Squamous Cell Carcinoma (Epidermoid Carcinoma)
09/2015
1Genetic Translocation (Chromosomal Translocation)
09/2015
1Carcinoid Tumor (Carcinoid)
09/2015
1Large Cell Carcinoma
09/2015
1Small Cell Carcinoma
09/2015
1Glandular and Epithelial Neoplasms (Neoplasms, Glandular)
09/2015
1Premature Aging
01/2015
1Carcinogenesis
01/2015
1Prostatic Neoplasms (Prostate Cancer)
01/2014
1Leukemia
12/2005

Drug/Important Bio-Agent (IBA)

7Biomarkers (Surrogate Marker)IBA
11/2021 - 12/2014
7Bevacizumab (Avastin)FDA Link
01/2021 - 08/2017
6Proteins (Proteins, Gene)FDA Link
01/2021 - 10/2004
5Phenobarbital (Luminal)FDA Link
12/2021 - 09/2007
4Estrogen ReceptorsIBA
01/2021 - 08/2017
3Messenger RNA (mRNA)IBA
01/2020 - 07/2014
2Hormones (Hormone)IBA
12/2021 - 02/2011
2human ERBB2 proteinIBA
01/2021 - 11/2020
2TamoxifenFDA LinkGeneric
01/2021 - 11/2017
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2021 - 09/2012
2Keratins (Keratin)IBA
11/2020 - 02/2011
2Biological ProductsIBA
01/2020 - 09/2010
2Pharmaceutical PreparationsIBA
10/2019 - 01/2019
2Epirubicin (Ellence)FDA LinkGeneric
11/2018 - 12/2014
2Fluorouracil (Carac)FDA LinkGeneric
11/2018 - 12/2014
2Cyclophosphamide (Cytoxan)FDA LinkGeneric
11/2018 - 12/2014
2DNA (Deoxyribonucleic Acid)IBA
11/2018 - 12/2016
2Docetaxel (Taxotere)FDA Link
12/2014 - 07/2014
2AntibodiesIBA
02/2011 - 10/2004
1Formaldehyde (Formol)FDA Link
12/2021
1ParaffinIBA
12/2021
1RNA (Ribonucleic Acid)IBA
12/2021
1Ado-Trastuzumab EmtansineIBA
11/2021
1pertuzumabIBA
11/2021
1Paclitaxel (Taxol)FDA LinkGeneric
11/2021
1Trastuzumab (Herceptin)FDA Link
11/2021
14-hydroxy-N-desmethyltamoxifenIBA
01/2021
1Factor VIII (Coagulation Factor VIII)IBA
01/2021
1CytokinesIBA
01/2020
1tyrosine receptor (receptor, tyrosine)IBA
01/2020
1Blood Proteins (Serum Proteins)IBA
01/2020
1Factor V (Coagulation Factor V)IBA
01/2020
1Protein Kinases (Protein Kinase)IBA
01/2020
1Growth Differentiation Factor 15IBA
01/2020
1Angiogenesis InhibitorsIBA
01/2019
1ProteomeIBA
01/2019
1taxaneIBA
11/2018
1Cytochrome P-450 CYP2D6 (CYP2D6)IBA
11/2017
1EnzymesIBA
11/2017
1Nut ProteinsIBA
09/2015
1Nuclear Proteins (Protein, Nuclear)IBA
09/2015
1Mammaglobin AIBA
07/2014
1Keratin-19 (Keratin 19)IBA
07/2014
1Cyclooxygenase 2 (Cyclooxygenase-2)IBA
10/2012
1Progesterone Receptors (Progesterone Receptor)IBA
10/2012
1Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA
09/2012
1Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA
09/2012
1Vascular Endothelial Growth Factor Receptor-1 (fms-Like Tyrosine Kinase)IBA
09/2012
1Indicators and Reagents (Reagents)IBA
05/2011
1Apoptosis Inducing FactorIBA
12/2005
15-aminolevulinic acid hexyl esterFDA Link
12/2005
1protoporphyrin IXIBA
12/2005
11-phenyl-3,3-dimethyltriazene (PDT)IBA
12/2005
1AcidsIBA
12/2005
1ErbB-2 ReceptorIBA
10/2004

Therapy/Procedure

11Therapeutics
12/2021 - 04/2008
8Neoadjuvant Therapy
01/2021 - 08/2012
6Drug Therapy (Chemotherapy)
12/2021 - 12/2014
1Hepatectomy
11/2015
1Castration
01/2014
1Photochemotherapy (Photodynamic Therapy)
12/2005